Citation Impact
Citing Papers
Jinx , an MCMV susceptibility phenotype caused by disruption of Unc13d : a mouse model of type 3 familial hemophagocytic lymphohistiocytosis
2007 StandoutNobel
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
A single-centre experience of post-renal transplant lymphoproliferative disorder
2003
The history of cancer epigenetics
2004 Standout
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
1998 Standout
Polymerase chain reaction amplification of archival material for epstein-barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis
1998
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
1998
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANTATION
1996
Impaired Long‐term T Cell Immunity to Epstein‐Barr Virus in Patients with Nasopharyngeal Carcinoma
1992
Cytokines in cancer immunity and immunotherapy
2004
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease
2003
Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice.
1991
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Molecular and cellular pathogenesis of X‐linked lymphoproliferative disease
2005
Mantle zone lymphoma: An immunohistologic study of skin lesions
1994
Treatment of Non-Hodgkin's Lymphoma
1993
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Epstein-Barr virus: exploiting the immune system
2001 Standout
Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus.
1987
INTERFERON-?? TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1
1998
X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery
1995
SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and Reveal Endothelial Niches for Stem Cells
2005 Standout
Systemic Lupus Erythematosus
2011 Standout
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 StandoutScience
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Hemophagocytic Syndromes and Infection
2000
Host Cell-Dependent Expression of Latent Epstein–Barr Virus Genomes: Regulation by DNA Methylation
2003
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells
2005
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Parvovirus B19
2004 Standout
Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes
1999 StandoutNobel
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
1993 Standout
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
Mammalian G1 cyclins
1993 Standout
Epstein–Barr Virus Infection
2000 Standout
NK CELL RECOGNITION
2004 Standout
Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus
2004
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
1986 Standout
The Three Es of Cancer Immunoediting
2004 Standout
Cloning of a cDNA for a T Cell-Specific Serine Protease from a Cytotoxic T Lymphocyte
1986 Science
Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains.
1987 StandoutNobel
Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus
1986
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Deficient Natural Killer Cell Activity in X-Linked Lymphoproliferative Syndrome
1980 Science
Cancer Cell Cycles
1996 StandoutScience
Lymphadenopathy-Associated-Virus Infection and Acquired Immunodeficiency Syndrome
1986 StandoutNobel
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes
1987
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas.
1994
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
1985 Standout
PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.
1991
Characterization of a candidate bcl-1 gene.
1991
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes
1999 StandoutNobel
Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes
1984 StandoutScienceNobel
Cancer after transplantation
1986
SLAM Family Receptors and SAP Adaptors in Immunity
2011
Epstein-Barr Virus (EBV) Induced Polyclonal and Monoclonal B-Cell Lymphoproliferative Diseases Occurring after Renal Transplantation
1983
Generalized Lymphadenopathy in Homosexual Men
1983
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
1992 Standout
Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2Rγnull Mice In Vivo
2009
Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells.
1999
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
1984 Standout
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
1999 Standout
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
1988
The occurrence of cancer in immune deficiencies
1982
X-Linked Lymphoproliferative Syndrome Registry report
1980
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
The scanning model for translation: an update.
1989 Standout
Cytokine production in the immune response to murine gammaherpesvirus 68
1996 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Epstein-Barr Virus Infections in Males with the X-Linked Lymphoproliterative Syndrome
1987
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of Purtilo Dt being referenced
Opportunistic non-Hodgkin's lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes.
1977
Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome.
1987
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings
1987
Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease
1988
The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient.
1994
The Epstein-Barr virus (EBV) in the pathogenesis of posttransplant lymphoma.
1981
Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome.
1979
Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
1985
Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease
1988
Defective immune surveillance in viral carcinogenesis.
1984
X-linked lymphoproliferative syndrome: abnormal antibody responses to bacteriophage phi X 174.
1983
Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
1985
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings
1987
Diverse familial malignant tumors and Epstein-Barr virus.
1981
Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis.
1989
Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
1986